Abstract:
Immunogenic proteins comprising Mycoplasma mycoides subsp. mycoides and M. mycoides subsp. capri proteins, encoding polynucleotides, a method for producing said proteins, and use of compositions to prevent M. mycoides subsp. mycoides infections are disclosed.
Abstract:
The use of GapC plasmin binding proteins from Streptococcus dysgalactiae (S. dysgalactiae) , Streptococcus agalactiae (S. agalactiae) , Streptococcus uberis (S. uberis) , Streptococcus parauberis (S. parauberis) , and Streptococcus iniae (S. iniae) in combination with CAMP factors is described, to prevent or treat bacterial infections in general, and mastitis in particular.
Abstract:
The use of GapC plasmin binding proteins from Streptococcus dysgalactiae (S. dysgalactiae) , Streptococcus agalactiae (S. agalactiae) , Streptococcus uberis (S. uberis) , Streptococcus parauberis (S. parauberis) , and Streptococcus iniae (S. iniae) in combination with CAMP factors is described, to prevent or treat bacterial infections in general, and mastitis in particular.
Abstract:
Mycoplasma bovis antigens for use in subunit vaccine compositions to elicit immune responses against M. bovis , polynucleotides encoding therefor, and use of said compositions to prevent Mycoplasma bovis infections.
Abstract:
The CAMP factor gene of Streptococcus uberis ( S. uberis ) is described, as well as the recombinant production of CAMP factor therefrom. Also disclosed are chimeric CAMP factor constructs, including CAMP factor epitopes from more than one bacterial species. The CAMP factors and chimeras including the same can be used in immunogenic compositions for the prevention and treatment of bacterial infections.
Abstract:
The GapC plasmin binding protein genes of Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S.iniae) are described, as well as the recombinant production of the GapC proteins therefrom. Also described is the use of the GapC proteins from those species in vaccine compositions to prevent or treat bacterial infections in general, and mastitis in particular.
Abstract:
The recombinant production of Gap4, a chimeric GapC plasmin binding protein comprising the entire amino acid sequence of the Streptococcus dysgalactiae GapC protein in addition to unique amino acid sequences from the Streptococcus parauberis and Streptococcus agalactiae GapC proteins, is described. Also described is the use of Gap4 chimeric GapC protein in vaccine compositions to prevent or treat streptococcal infections in general and mastitis in particular.
Abstract:
The use of GapC plasmin binding proteins from Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S. iniae) in combination with CAMP factors is described, to prevent or treat bacterial infections in general, and mastitis in particular.
Abstract:
The GapC plasmin binding protein genes of Streptococcus dysgalactiae (S. dysgalactiae), Streptococcus agalactiae (S. agalactiae), Streptococcus uberis (S. uberis), Streptococcus parauberis (S. parauberis), and Streptococcus iniae (S.iniae) are described, as well as the recombinant production of the GapC proteins therefrom. Also described is the use of the GapC proteins from those species in vaccine compositions to prevent or treat bacterial infections in general, and mastitis in particular.